Ceesay Abrahaminsider trades
In SEC Form 4 filings, Ceesay Abraham is listed as Chief Executive Officer of Rapport Therapeutics, Inc. (RAPP). In the last 90 days, Ceesay Abraham sold $1.61M of Rapport Therapeutics, Inc. (RAPP) on the open market and bought none. All 9 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| RAPPRapport Therapeutics, Inc. | Chief Executive Officer | 9 | Oct 23 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-26
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RAPPRapport Therapeutics, Inc. | Oct 21 | Oct 23 | S | 2,210 | $29.16 | Sale −$64,448 | 450,035 | Yes | Form 4 |
| RAPPRapport Therapeutics, Inc. | Oct 7 | Oct 8 | S | 1,147 | $30.66 | Sale −$35,167 | 452,245 | Yes | Form 4 |
| RAPPRapport Therapeutics, Inc. | Oct 6 | Oct 8 | S | 3,375 | $32.03 | Sale −$108,106 | 453,392 | Yes | Form 4 |
| RAPPRapport Therapeutics, Inc. | Sep 23 | Sep 24 | S | 1,952 | $39.05 | Sale −$76,230 | 457,025 | Yes | Form 4 |
| RAPPRapport Therapeutics, Inc. | Sep 23 | Sep 24 | S | 215 | $39.86 | Sale −$8,570 | 456,810 | Yes | Form 4 |
| RAPPRapport Therapeutics, Inc. | Sep 23 | Sep 24 | S | 43 | $41.05 | Sale −$1,765 | 456,767 | Yes | Form 4 |
| RAPPRapport Therapeutics, Inc. | Sep 8 | Sep 9 | S | 7,141 | $45.56 | Sale −$325,308 | 460,046 | Yes | Form 4 |
| RAPPRapport Therapeutics, Inc. | Sep 8 | Sep 9 | S | 1,069 | $46.01 | Sale −$49,190 | 458,977 | Yes | Form 4 |
| RAPPRapport Therapeutics, Inc. | Aug 25 | Aug 26 | S | 18,921 | $49.57 | Sale −$937,957 | 467,187 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.